What does Sol-Gel Technologies Ltd. do?

Jun 22 2025 06:29 PM IST
share
Share Via
Sol-Gel Technologies Ltd. is a clinical-stage dermatology company focused on developing topical drug products for skin diseases. As of March 2025, it has a market cap of $19.51 million, with net sales of $1 million and a net loss of $9 million.
Overview:
Sol-Gel Technologies Ltd. is a clinical-stage dermatology company focused on developing and commercializing branded and generic topical drug products for the treatment of skin diseases, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company. Financial Snapshot: Net Sales: 1 Million (Quarterly Results - Mar 2025) Net Profit: -9 Million (Quarterly Results - Mar 2025) Market cap: USD 19.51 Million (Micro Cap) Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -0.82 Return on Equity: -64.66% Price to Book: 0.97 Contact Details: Address: Weizmann Science Park, 7, Golda Me'ir, NESS-ZIONA None: 7403650 Tel: ['972 8 9313433'] Fax: 972 8 9313434 Website: http://www.sol-gel.com
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News